Deuterium Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,000	Closed	-$1.13M	–	53
2022 Q1	$1.13M	Hold	18,000	–	–	1.45%	13
2021 Q4	$1.36M	Buy	+18,000	New	+$1.36M	2.02%	10